Detalhe da pesquisa
1.
Fentanyl-induced respiratory depression in rodents is inhibited by bioabsorbable, subcutaneous naltrexone implants at 3.5 months.
Addict Biol
; 28(12): e13350, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38017645
2.
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial.
Am J Addict
; 32(3): 291-300, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36645265
3.
A pilot test of Written Exposure Therapy for PTSD in residential substance use treatment.
Am J Addict
; 32(5): 488-496, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37329251
4.
Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable Naltrexone.
Subst Use Misuse
; 57(11): 1732-1742, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35975917
5.
Assessing clinical impacts and attitudes related to COVID-19 among residential substance use disorder patients.
Subst Abus
; 43(1): 756-762, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35112980
6.
Opioid use disorder Cascade of care framework design: A roadmap.
Subst Abus
; 43(1): 1207-1214, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35657670
7.
Towards an International Consensus on the Prevention, Treatment, and Management of High-Risk Substance Use and Overdose among Youth.
Medicina (Kaunas)
; 58(4)2022 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35454376
8.
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions.
Oncologist
; 26(8): e1418-e1426, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33586299
9.
Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial.
Am J Addict
; 30(5): 433-444, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34075644
10.
Until there's nothing left: Caregiver resource provision to youth with opioid use disorders.
Subst Abus
; 42(4): 990-997, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33759732
11.
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.
Lancet
; 391(10118): 309-318, 2018 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29150198
12.
Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.
N Engl J Med
; 374(13): 1232-42, 2016 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-27028913
13.
Working Memory Training for Adolescents With Cannabis Use Disorders: A Randomized Controlled Trial.
J Child Adolesc Subst Abuse
; 27(4): 211-226, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30524179
14.
Trait Mindfulness and Progression to Injection Use in Youth With Opioid Addiction.
Subst Use Misuse
; 52(11): 1486-1493, 2017 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28471275
15.
Relapse prevention medications in community treatment for young adults with opioid addiction.
Subst Abus
; 37(3): 392-397, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26820059
16.
Working memory impairment in cannabis- and opioid-dependent adolescents.
Subst Abus
; 35(4): 387-90, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25148203
17.
A pilot randomized controlled trial of medication adherence therapy: Psychosocial leverage using a significant other (MAT-PLUS) for individuals on extended-release naltrexone.
J Subst Use Addict Treat
; 163: 209366, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38636807
18.
Patient and provider medication preferences affect treatment outcomes among adolescents and young adults with opioid use disorder.
J Subst Use Addict Treat
; 162: 209334, 2024 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531508
19.
Engagement, initiation, and retention in medication treatment for opioid use disorder among young adults: A narrative review of challenges and opportunities.
J Subst Use Addict Treat
; : 209352, 2024 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494051
20.
Stress Exposure and PTSD in a Cross-Sectional Residential Substance Use Treatment Sample.
Subst Use Addctn J
; : 29767342241248978, 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38717128